AXIANGE

Serial Number 78852518
601

Registration Progress

Application Filed
Apr 3, 2006
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

AXIANGE

Basic Information

Serial Number
78852518
Filing Date
April 3, 2006
Abandonment Date
May 2, 2007
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
601
Status Date
May 7, 2007
Classes
005

Rights Holder

Agouron Pharmaceuticals, Inc.

03
Address
10777 Science Center Drive
San Diego, CA 92121

Ownership History

Agouron Pharmaceuticals, Inc.

Original Applicant
03
San Diego, CA

Legal Representation

Attorney
Christopher N. Bolinger

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

14 events
Date Code Type Description Documents
May 7, 2007 ABN1 O ABANDONMENT - EXPRESS MAILED Loading...
May 7, 2007 MAB1 O ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT Loading...
May 2, 2007 ALIE A ASSIGNED TO LIE Loading...
May 2, 2007 LOAP I LETTER OF ABANDONMENT PROCESSED Loading...
Apr 3, 2007 MAIL I PAPER RECEIVED Loading...
Nov 30, 2006 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 30, 2006 CNRT F NON-FINAL ACTION MAILED Loading...
Nov 27, 2006 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Oct 20, 2006 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Sep 27, 2006 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 22, 2006 ALIE A ASSIGNED TO LIE Loading...
Sep 15, 2006 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 14, 2006 DOCK D ASSIGNED TO EXAMINER Loading...
Apr 7, 2006 NWAP I NEW APPLICATION ENTERED IN TRAM Loading...

Detailed Classifications

Class 005
pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, urogenital disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, premature ejaculation, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological disorders, viral disorders, fungal disorders; pharmaceutical preparations namely, cholesterol preparations, insomnia preparations, smoking cessation preparations, dermatological preparations, gynecological preparations, osteoporosis preparations and ophthalmological preparations
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005